Ramelteon: all 66 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Doxepin Alone or Combined With Ramelteon Versus Placebo for Improving Sleep Quality After Primary Total Knee ArthroplastyNot yet recruitingNCT07598734Phase 4
• A Study of Ramelteon in Chinese Patients With Chronic InsomniaNot yet recruitingNCT06512363Phase 3
• Delirium Reduction With RamelteonRecruitingNCT05069428Phase 4
• Ramelteon for Treatment of Insomnia in CirrhosisCompletedNCT03091738Phase 4Results posted
• The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) SurgeryStatus unknownNCT02691013Not applicableResults posted
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyCompletedNCT02669082Phase 4Results posted
• Effect of Ramelteon on Smoking AbstinenceCompletedNCT02560324Phase 2Results posted
• Ramelteon in the Prevention of Post-operative DeliriumCompletedNCT02324153Phase 2Results posted
• Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin ResistanceCompletedNCT02156271Phase 4Results posted
• Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 DisorderTerminatedNCT01677182Phase 3Results posted
• Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)CompletedNCT01048242Phase 3Results posted
• Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy AdultsCompletedNCT00914862Phase 1Results posted
• Ramelteon for Insomnia Comorbid With AsthmaTerminatedNCT00869167Phase 3Results posted
• Safety and Efficacy Study of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00756002Phase 3Results posted
• Clinical Management of Neuropathic Pain With RamelteonTerminatedNCT00753623Not applicableResults posted
• Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for AnxietyTerminatedNCT00746239Not applicableResults posted
• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and ParkinsonismTerminatedNCT00745030Not applicableResults posted
• A Study of a Melatonin Receptor Agonist to Prevent MigraineTerminatedNCT00739024Phase 2Results posted
• Time to Remission of Depressive Symptoms With Combined SSRI and RamelteonTerminatedNCT00642694Phase 3Results posted
• Ramelteon for Treatment of Adult Patients With ADHD-Related InsomniaCompletedNCT00622427Phase 4Results posted
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaCompletedNCT00595504Phase 4Results posted
• Ramelteon for a Nap Prior to a Night ShiftCompletedNCT00595075Not applicableResults posted
• Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase SyndromeCompletedNCT00593736Phase 2Results posted
• Improving Sleep in Nursing HomesCompletedNCT00576927Phase 4Results posted
• Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar DisorderCompletedNCT00552760Phase 4Results posted
• Functional Melatonin Replacement for Sleep Disruptions in Individuals With TetraplegiaCompletedNCT00507546Phase 4Results posted
• Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective DisorderCompletedNCT00502320Phase 4Results posted
• Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00492232Phase 4Results posted
• Treating Chronic Insomnia in Breast Cancer PatientsTerminatedNCT00337272Phase 4Results posted
• Melatonin Agonist for Shift-time Workers.CompletedNCT07382843Phase 4
• Insomnia Prevalence and Treatment Impact on Systemic HypertensionTerminatedNCT05414864Phase 4
• Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19Status unknownNCT04470297Phase 2
• The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICUCompletedNCT03931070Phase 4
• The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic InsomniaCompletedNCT03461042Phase 4
• Ramelteon for Complex Insomnia in Veterans With PTSDWithdrawnNCT03265951Phase 4
• Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older AdultsWithdrawnNCT03165695Phase 4
• Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With SchizophreniaCompletedNCT03075657Phase 4
• Ramelteon and Citicoline for DeliriumWithdrawnNCT02840591Phase 4
• Ramelteon Prevention of Delirium - RCTStatus unknownNCT02564939Phase 4
• A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 DisorderWithdrawnNCT01685151Phase 3
• Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior DisorderCompletedNCT01401413Phase 4
• Effect of Rozerem on Sleep Among People With Traumatic Brain InjuryStatus unknownNCT01207050Phase 4
• Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic InsomniaStatus unknownNCT01180855Phase 4
• Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.Status unknownNCT01128582Phase 3
• Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With RamelteonWithdrawnNCT00907595Not applicable
• The Effect of Marijuana and Prescription Medications in Mood, Performance and SleepCompletedNCT00893269Phase 1
• Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?CompletedNCT00811746Not applicable
• Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With InsomniaCompletedNCT00755508Phase 2
• Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic InsomniaCompletedNCT00755495Phase 2
• Efficacy of Ramelteon in Adults With Chronic InsomniaTerminatedNCT00672724Phase 3
• Ramelteon in Adults With Chronic InsomniaCompletedNCT00671567Phase 3
• Efficacy of Ramelteon on Transient Insomnia in Healthy AdultsCompletedNCT00671398Phase 3
• Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic InsomniaCompletedNCT00671255Phase 3
• Safety and Efficacy of Ramelteon in Healthy SubjectsCompletedNCT00671190Phase 2
• Study of Efficacy of Ramelteon in Adults With Chronic InsomniaCompletedNCT00671125Phase 3
• Efficacy of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00671086Phase 3
• Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic InsomniaCompletedNCT00656994Phase 3
• Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep DisturbanceTerminatedNCT00585208Phase 3
• Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult VolunteersCompletedNCT00492011Phase 4
• Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's DiseaseTerminatedNCT00462254Phase 4
• Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.CompletedNCT00414102Phase 4
• A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine HeadachesTerminatedNCT00391755Phase 4
• Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00325728Phase 2
• Effects of Ramelteon on Driving AbilityCompletedNCT00319215Phase 1
• Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.CompletedNCT00247390Phase 3
• Safety and Efficacy of Ramelteon in Adults With Chronic InsomniaCompletedNCT00237497Phase 3

← Ramelteon overview